Paper8242539
Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
Wooten MD and 1 other. Cancer, 1993. Cited by 266 papers, by iCite.
Cite this record
ConductScience Library. Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature. Papers, record 8242539. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8242539
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Cortex Neoplasms | Major topic |
| Adrenocortical Carcinoma | Major topic |
| Mitotane | Major topic |
| Adolescent | |
| Adrenal Cortex | |
| Adult | |
| Age Factors | |
| Aged | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Neoplasm Staging | |
| Remission Induction | |
| Retrospective Studies | |
| Sex Factors | |
| Survival Rate |
Source PubMed
Cited by77
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 266 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42137725 | Pseudo-Progression Observed During Immune Checkpoint Inhibitor Therapy for Advanced Adrenocortical Carcinoma. | IJU Case Rep | 2026 | https://conductscience.org/library/papers/42137725 | PubMed |
| 40206460 | Geographical Variation in Adrenocortical Carcinoma Incidence Across Colorado. | J Endocr Soc | 2025 | https://conductscience.org/library/papers/40206460 | PubMed |
| 40014786 | Management of adrenocortical carcinoma in Slovenia: a real-life analysis of histopathologic markers, treatment patterns, prognostic factors, and survival. | Radiol Oncol | 2025 | https://conductscience.org/library/papers/40014786 | PubMed |
| 39263332 | Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery. | Cancer Manag Res | 2024 | https://conductscience.org/library/papers/39263332 | PubMed |
| 39071458 | Circadian rhythm disruption and endocrine-related tumors. | World J Clin Oncol | 2024 | https://conductscience.org/library/papers/39071458 | PubMed |
| 38463201 | Surgical Management of Metastatic Adrenocortical Carcinoma. | World J Surg | 2024 | https://conductscience.org/library/papers/38463201 | PubMed |
| 37925657 | Defining Optimal Management of Non-metastatic Adrenocortical Carcinoma. | Ann Surg Oncol | 2024 | https://conductscience.org/library/papers/37925657 | PubMed |
| 37829670 | Rare Tumors: Opportunities and challenges from the Children's Oncology Group perspective. | EJC Paediatr Oncol | 2023 | https://conductscience.org/library/papers/37829670 | PubMed |
| 37297933 | Review of Diagnostic Modalities for Adrenal Incidentaloma. | J Clin Med | 2023 | https://conductscience.org/library/papers/37297933 | PubMed |
| 37185426 | A Clinicopathological Analysis of Asian Patients with Adrenocortical Carcinoma: A Single-Center Experience. | Curr Oncol | 2023 | https://conductscience.org/library/papers/37185426 | PubMed |
| 36151566 | Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/36151566 | PubMed |
| 35983531 | Comprehensive Multiomics Analysis Reveals Potential Diagnostic and Prognostic Biomarkers in Adrenal Cortical Carcinoma. | Comput Math Methods Med | 2022 | https://conductscience.org/library/papers/35983531 | PubMed |
| 35865995 | Adrenal Mass in a 70-Year-Old Woman. | Case Rep Endocrinol | 2022 | https://conductscience.org/library/papers/35865995 | PubMed |
| 35782795 | Adrenocortical Carcinoma: a Therapeutic Challenge - 44 Cases from a Single Tertiary Care Center in India. | Indian J Surg Oncol | 2022 | https://conductscience.org/library/papers/35782795 | PubMed |
| 35681785 | Prediction of Adrenocortical Carcinoma Relapse and Prognosis with a Set of Novel Multigene Panels. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35681785 | PubMed |
| 35580936 | Iliac vein deep vein thrombosis as an atypical presentation of an adrenocortical carcinoma. | BMJ Case Rep | 2022 | https://conductscience.org/library/papers/35580936 | PubMed |
| 34850915 | Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival. | J Clin Endocrinol Metab | 2022 | https://conductscience.org/library/papers/34850915 | PubMed |
| 34559356 | Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? | Endocrine | 2021 | https://conductscience.org/library/papers/34559356 | PubMed |
| 34349894 | Adrenocortical carcinoma: current state of the art, ongoing controversies, and future directions in diagnosis and treatment. | Ther Adv Chronic Dis | 2021 | https://conductscience.org/library/papers/34349894 | PubMed |
| 34148966 | Adrenocortical Carcinoma Diagnosed by Endoscopic Ultrasound-guided Fine-needle Aspiration. | Intern Med | 2021 | https://conductscience.org/library/papers/34148966 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8242539
GET https://conductscience.org/api/papers/v1/8242539/cited_by?page=2